Category:

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.

Kyle Bass, Hayman Capital Management founder and... (video)

Clio Healthcare award winners for 2015 are out, AstraZeneca's "Take it From a Fish" work--got a second-place silver Clio. That campaign, which took home the grand prize at the summer Cannes Health Lion show, features two wise-cracking grocery store fish on ice talking about the importance of lowering triglycerides. "Fish" also won two bronze awards in digital and social categories.

Abbott Healthcare is challenging an Indian state's accusation that a sample of the company's cough syrup contained excessive levels of codeine,...the laboratory found that a sample of Phensedyl contained more than twice the labeled amount of codeine,..Abbott denied the allegations and urged regulators to not take any action. Abbott said it had found nothing unusual in its own and third party testing of a retained sample from the same batch of Phensedyl....also asked regulators to give it more information about the source of the suspect sample and the manner in which it was collected, so that it could establish whether it was genuine and proper process was followed.

Concierge pharmacists are working directly in physicians’ offices to personalize chronic care medication management for patients…. delivering chronic care medication services at the point of care… services can produce better patient outcomes, lower health care costs, and improve Medicare Star Ratings, according to RXVIP… pharmacists pay a visit to the physician’s office 1 day a week…review and evaluate drug interactions, dosing, adverse effects, and adherence. Patients will also be encouraged to make lifestyle changes if necessary…pharmacists employ the CeutiCare ICG Intelligent Clinical Guidance system, which monitors patients and provides medication therapy treatment plans for the physician to review...

...there are roughly 30 million Americans who suffer from a rare disease. And sadly, about 50% are children.. FDA…recently released a new resource for drug developers — a draft guidance document — designed to help them navigate the difficult and unique challenges of developing and bringing to market…drugs to treat rare diseases...document is intended to encourage drug developers to think early on in the process about all aspects of their program — and encourages careful planning which includes a foundation in strong science. Drug developers for rare diseases are often pioneers…this guidance as another important resource to help support their efforts.

Statins are tried-and-true moneymakers, but they also come with their own set of safety concerns…FDA postmarketing safety reports… on side effects for companies producing statin drugs…found that Merck's Zocor, Mevacor and Vytorin were associated with more muscle-related side effects than other drugs in the class…For example, Zocor had 4275 reports of myalgia, 632 reports of myopathy, and 3552 cases of rhabdomyolysis..

Are pharmaceuticals a good investment right now, during the wake of anticipated rising interest rates? JPMorgan Chase & Co. thinks so...The analyst especially favors the large-cap pharmaceuticals such as...

• Allergan plc,
• Valeant Pharmaceuticals International, Inc.
• Teva Pharmaceutical Industries Limited
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Endo International plc
• Akorn, Inc.

Would a rate hike hurt consolidation in the biotech sector? CNBC's Meg Tirrell provides insight to whether there is reason to worry if rates go higher.

For the seventh consecutive year, Roche been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry…. three elements of sustainability - societal, environmental and economic - are completely integrated into our business practices… Roche has maintained its leadership position in the pharmaceuticals industry…including code of conduct and compliance, risk and crisis management, supply chain management, environmental policy and management, talent attraction and retention...